Korean medicinal plants inhibiting to human immunodeficiency virus type 1 (HIV-1) fusion

Phytotherapy Research

Volumn 17, Issue 4, 2003, Pages 426-429

  Chang, Young Su ^a   Woo, Eun Rhan ^a  

^a Chosun University   (South Korea)

Author keywords

Ailanthus altissima; Anti HIV; Gp120 41; Korean plants; Syncytia

Indexed keywords

ACANTHOPANAX SESSILIFLORUS EXTRACT; ACHYRANTHES JAPONICA EXTRACT; ACONITUM EXTRACT; ADENOPHORA TRIPHYLLA EXTRACT; AILANTHUS ALTISSIMA EXTRACT; AKEBIA QUINATA EXTRACT; ALPINIA OFFICINARUM EXTRACT; ANTIVIRUS AGENT; ARISTOLOCHIA CONTORTA EXTRACT; ARTEMISIA CAPILLARIS EXTRACT; ATRACTYLODES EXTRACT; BRASSICA JUNCEA EXTRACT; CD4 ANTIGEN; CELL MEMBRANE PROTEIN; CURCUMA LONGA EXTRACT; DIOSCOREA BATATAS EXTRACT; DIOSCOREA TOKORO EXTRACT; FOENICULUM VULGARE EXTRACT; GINKGO BILOBA EXTRACT; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; LINDERA STRYCHNIFOLIA EXTRACT; METHANOL; PAEONIA ALBIFLORA EXTRACT; PEPPERMINT OIL; PLANT EXTRACT; PRUNUS PERSICA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS ENVELOPE PROTEIN; VITEX ROTUNDIFOLIA EXTRACT;

ACANTHOPANAX SESSILIFLORUS; ACHYRANTHES JAPONICA; ACONITUM JALUENSE; ADENOPHORA TRIPHYLLA; AKEBIA QUINATA; ALPINIA OFFICINARUM; ARISTOLOCHIA; ARISTOLOCHIA CONTORTA; ARTEMISIA; ARTEMISIA CAPILLARIS; ARTICLE; ATRACTYLOIDES JAPONICA; BARK; BRASSICA; BRASSICA JUNCEA; CONCENTRATION RESPONSE; DIOSCOREA BATATAS; DIOSCOREA TOKORO; DRUG ISOLATION; FENNEL; GINKGO BILOBA; HUMAN IMMUNODEFICIENCY VIRUS 1; INHIBITION KINETICS; KOREA; LINDERA; LINDERA STRYCHNIFOLIA; MEDICINAL PLANT; NONHUMAN; PAEONIA ALBIFLORA; PROTEIN PROTEIN INTERACTION; PRUNUS PERSICA; T LYMPHOCYTE; VIRUS INHIBITION; VITEX ROTUNDIFOLIA; YAM;

AILANTHUS; ANTI-HIV AGENTS; FEMALE; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; KOREA; MEDICINE, TRADITIONAL; MEMBRANE FUSION; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; PLANTS, MEDICINAL;

AILANTHUS ALTISSIMA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0038559795     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1155     Document Type: Article

References (10)

1. Earl PL, Hugen AW, Moss B. 1990. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus. J Virol 64: 2448-2451.
2. Kim HJ, Lee JS, Woo E-R, et al. 2001. Isolation of virus-cell fusion inhibitory components from Eugenia caryophyllata. Planta Med 67: 277-279.
3. Lin P-F, Samanta H, Bechtold CM, et al. 1996. Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor. Antimicrob Agents Chemother 40: 133-138.
4. Mayaux J-F, Bousseau A, Pauwels R, et al. 1994. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proc Natl Acad Sci USA 91: 3564-3568.
5. Moore JP. 1997. Coreceptors: implications for HIV pathogenesis and therapy. Science 276: 51-52.
6. Nishizawa Y, Seto T, Watanabe Y, Yasuda I. 1977. Studies on the components of Atractylodes. III. New sesquiterpene the rhizome of Atractylodes japonica. Yakugaku Zasshi 97: 515-518.
7. Pereira FB, Goni FM, Nieva JL. 1995. Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution. FEBS Lett 362: 243-246.
8. Rahman S, Fukamiya N, Okano M, Tagahara K, Lee K-H. 1997. Anti-tuberculosis activity of quassinoids. Chem Pharm Bull 45: 1527-1529.
9. Ryu J-R, Jin B-S, Suh M-J, et al. 1999. Two interaction modes of the gp41-derived peptides with gp41 and their correlation with antimembrane fusion activity. Biochem Biophys Res Commun 265: 625-629.
10. Tochikura TS, Nakashima H, Tanabe A, Yamamoto N. 1988. Human immunodeficiency virus (HIV)-induced cell fusion: Quantification and its application for the simple and rapid screening of anti-HIV substances in vitro. Virology 164: 542-546.